Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Centocor’s $1.8B award in Remicade patent case overturned
Bizjournals.com
Thursday, February 24, 2011 - 11:18pm
tags:
Remicade, Abbott Laboratories, patents, Janssen Biotech
Lexicon Pharma's 4Q loss widens as costs rise
Yahoo/AP
Thursday, February 24, 2011 - 11:14pm
tags:
earnings, Lexicon Pharmaceuticals
Human Genome Sciences takes bigger 4Q loss
Yahoo/AP
Thursday, February 24, 2011 - 11:11pm
tags:
earnings, Human Genome Sciences
Is Novartis the Perfect Stock?
Motley Fool
Thursday, February 24, 2011 - 11:04pm
tags:
Novartis
Should You Retire With Merck?
Motley Fool
Thursday, February 24, 2011 - 5:53pm
tags:
Merck
Former Glaxo Lawyer: Name My Co-Conspirators
Pharmalot
Thursday, February 24, 2011 - 5:32pm
tags:
GSK, Wellbutrin SR, off-label, lawsuits
ViroPharma 4Q profit triples on sales
Yahoo/AP
Thursday, February 24, 2011 - 11:41am
tags:
earnings, ViroPharma
Is This the Biggest Threat to Drug Investors?
Motley Fool
Thursday, February 24, 2011 - 11:35am
tags:
investors, Pharmaceutical Market Access and Drug Safety Act, Pfizer, Merck, Eli Lilly
Pozen migraine drug fails to get patent extension
Reuters
Thursday, February 24, 2011 - 8:47am
tags:
Pozen, migraines, patents, GSK, Treximet
Federal judge rules health reform legal
Bizjournals.com
Thursday, February 24, 2011 - 8:35am
tags:
healthcare reform
Pfizer Taps Beer Skills to Enter $14 Billion Insulin Market
Bloomberg
Thursday, February 24, 2011 - 8:32am
tags:
Pfizer, insulin, diabetes
House Committee Targets FDA In Heparin Probe
Pharmalot
Wednesday, February 23, 2011 - 11:47pm
tags:
Heparin, FDA, China
Takeda seeks U.S. approval of hypertension drug
Reuters
Wednesday, February 23, 2011 - 11:40pm
tags:
antihypertensives, Takeda
Pfizer puts remaining Trovan lawsuits to rest
Yahoo/AP
Wednesday, February 23, 2011 - 11:36pm
tags:
Pfizer, lawsuits, Trovan
FDA: Sanofi slow to report adverse events
Fierce Pharma
Wednesday, February 23, 2011 - 11:29pm
tags:
FDA, adverse events, Sanofi
Abbott Wins Reversal of J&J’s $1.67 Billion Patent Victory
Bloomberg
Wednesday, February 23, 2011 - 10:56pm
tags:
JNJ, Humira, Abbott Laboratories
Pfizer’s Crizotinib Wipes Out Rare Lymphoma in Two Test Cases
Bloomberg
Wednesday, February 23, 2011 - 10:52pm
tags:
Pfizer, crizotinib, lymphoma
Exelixis: Going Where No Drug Has Gone Before
Seeking Alpha
Wednesday, February 23, 2011 - 10:47pm
tags:
Exelixis, cabozantinib, prostate cancer
Why AEterna Zentaris Still Retains 200% to 300% Upside Potential
Seeking Alpha
Wednesday, February 23, 2011 - 10:44pm
tags:
Aeterna Zentaris
Onyx reports bigger 4Q loss as research costs grow
Yahoo/AP
Wednesday, February 23, 2011 - 10:41pm
tags:
ONYX Pharmaceuticals, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.